Urothelial Carcinoma of the Renal Pelvis and Ureter
📧 Sign up to get email alerts when something new happens for Urothelial Carcinoma of the Renal Pelvis and Ureter.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer [Phase 2, Phase 3]
A clinical trial is evaluating adding durvalumab to chemotherapy before surgery in patients with high-grade upper urinary tract urothelial c…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
University of Washington is conducting a trial to collect blood and tissue samples from patients with locally recurrent or metastatic prosta…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Sacituzumab Govitecan Plus EV in Metastatic UC [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating sacituzumab govitecan in combination with Enfortumab Vedotin for metastatic urothelial cancer; the …
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: 9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma [Phase 2]
Phase 2 trial evaluating 9MW2821 plus toripalimab versus 9MW2821 alone as first-line treatment for locally advanced or metastatic urothelial…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Named Patient Program for Mitomycin for Pyelocalyceal Solution
This clinical-trials.gov update describes a named patient program for mitomycin-C delivered as a pyelocalyceal solution to treat urothelial …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.